FDA PMA FDA Class 3 Approved 🇺🇸 United States

Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring

PMA: P050018 · Supplement: S026 · Decision Sep 11, 2020
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring
Trade Name
AngioSculpt PTCA Scoring Balloon Catheter, Rapid Exchange (RX)
PMA Number
P050018
Supplement Number
S026
Device Class
FDA Class 3
Product Code
NWX
Generic Name
Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 11, 2020
Date Received
July 9, 2019
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for various design changes, including additional coating to the transition tube and modifications to the balloon, distal tip, and scoring element.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NWX Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring